'Let's not become part of that war between the different firms, because it's already visible'
Number of locations down from 120,000 to 60,000 from April 3 to 7
Four serious cases of rare blood clots with low platelets have been reported after inoculation with J&J's vaccine from its Janssen unit
In India, Serum Institute of India is manufacturing AstraZeneca's vaccine under the brand Covishield
India could resume vaccine exports by June, the firm's chief executive, Adar Poonawalla, told media this week
A million doses from the Indian company already delivered have been sold on to other countries in the African Union.
The level of risk from an extremely rare form of blood clot being investigated as possible link with the Oxford/AstraZeneca vaccine is at the same as taking a long-haul flight, UK health minister said
Australia on Thursday become the latest country to restrict use of the AstraZeneca vaccine by recommending that it not be given to people under age 50
Reviews by UK and EU regulators finding potential links to the unusual side effects are another blow for the shot, a cheaper and easier-to-deploy product that many nations are counting on
The pan-European STOXX 600 rose 0.5% by 0720 GMT,
British say benefits outweigh risks for vast majority. Most cases of blood clots found in women under 60, EMA says
Oxford pauses trial among children; UK offers alternative to under-30s
The UK's medicines regulator said that under-30s in the country will be offered an alternative to the Oxford/AstraZeneca COVID-19 vaccine due to evolving evidence linking it to rare blood clots
Meanwhile, the EU's drug regulator says it has found a possible link between the AstraZeneca coronavirus vaccine and a rare clotting disorder
Researchers at Oxford University have paused an ongoing pediatric clinical trial of the coronavirus vaccine it is developing with AstraZeneca
There is a causal link between the coronavirus vaccine developed by AstraZeneca and very rare cases of blood clots, said a senior European Medicines Agency (EMA) expert
For the next one or two months, we will be prioritising supplies only to India based on the request of the government and also depending on the needs of our people, said Poonawalla
The world's largest vaccine maker, based in India, will be able to restart exports of AstraZeneca doses by June if new coronavirus infections subside in the country, its chief executive said Tuesday
Top official at the European Medicines Agency said in an interview published Tuesday there is a causal link between AstraZeneca's coronavirus vaccine and rare blood clots, but that it's still unclear
Nepal will start its second phase of the Covid-19 inoculation drive from April 7 using a China-donated vaccine to fight against the deadly infection